The importance of epigenetics in AML pathology was demonstrated by the identification of recurrent mutations in genes encoding epigenetic regulators, such as DNA methyltransferase 3A (DNMT3A), Tet methylcytosine dioxygenase 2 (TET2), and IDH1/2 [247]. This evidence concerns the gene IDH1 and acute myeloid leukemia.